On March 23, 2023, ASTHO President Anne Zink testified before the U.S. House of Representatives Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
On Dec. 15, 2021, ASTHO released its list of the top 10 state public health policy issues to watch in 2022. Although COVID-19 did not make the “official” list, it is woven into the management plan for nearly every trend. The 10 public ...
ASTHO CEO Michael Fraser's Testimony in Regards to the U.S. Department of Health and Human Services for the Committee on Appropriations, United States Senate
As 2019 comes to a close, it is important to reflect back on the numerous public health accomplishments and acknowledge the ongoing challenges we can expect to face in 2020.
ASTHO has its Federal Legislative Agenda priorities set for 2020.
ASTHO's 2022 Hill Day was nothing short of a success and we remain cautiously optimistic for an in-person Hill Day in 2023. We look forward to continuing our work to ensure we meet state and territorial health departments’ advocacy ...
Flavored tobacco policy has changed rapidly over the past few months. In April, FDA announced their intention to implement rules prohibiting the sale of menthol e-cigarettes and flavored cigars, though it may take years until they ...
On March 23, 2023, ASTHO President Anne Zink testified before the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies regarding sustainable and flexible public health funding.
On April 4, 2022, the U.S. Senate indicated that they have reached an agreement on a $10 billion bipartisan emergency supplemental funding bill for the federal COVID-19 response.
Federal Government Affairs ASTHO offers personalized legislative and advocacy expertise to our members. Additionally, ASTHO helps prepare them to provide testimony before Congress or participate in congressional briefings. We also provide ...